QuidelOrtho (QDEL) Depreciation & Amortization (CF) (2021 - 2026)
QuidelOrtho's (QDEL) quarterly Depreciation & Amortization (CF) came in at $112.9 million in Q1 2026, up 5.42% year-on-year from $107.1 million in Q1 2025, and little changed quarter-over-quarter from $112.5 million in Q4 2025.
QuidelOrtho (QDEL) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
QuidelOrtho has disclosed Depreciation & Amortization (CF) across 6 years of filings, most recently posting $112.9 million for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $112.9 million, up 5.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $447.8 million (changed 0.49% YoY), and the FY2025 annual result was $442.0 million, down 2.51% from the prior year.
- Depreciation & Amortization (CF) came in at $112.9 million for Q1 2026 at QuidelOrtho, roughly flat from $112.5 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $246.3 million in Q1 2023 to a low of $15.3 million in Q2 2022.
- The 5-year median for Depreciation & Amortization (CF) is $112.9 million (2026), against an average of $110.5 million.
- Across the five-year window, Depreciation & Amortization (CF) jumped 720.47% in 2022 and plunged 53.15% in 2023, its largest moves.
- QuidelOrtho's Depreciation & Amortization (CF) stood at $104.2 million in 2022, then rose by 10.75% to $115.4 million in 2023, then declined by 5.29% to $109.3 million in 2024, then gained by 2.93% to $112.5 million in 2025, then advanced by 0.36% to $112.9 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $112.9 million (Q1 2026), $112.5 million (Q4 2025), and $112.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | QuidelOrtho | 934.34 Mn | 793.94 Mn | - | 112.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 112.90 Mn |
| Mar 29, 2026 | 112.90 Mn |
| Dec 28, 2025 | 112.50 Mn |
| Dec 28, 2025 | 112.50 Mn |
| Sep 28, 2025 | 112.10 Mn |
| Sep 28, 2025 | 112.10 Mn |
| Jun 29, 2025 | 110.30 Mn |
| Jun 29, 2025 | 110.30 Mn |
| Mar 30, 2025 | 107.10 Mn |
| Mar 30, 2025 | 107.10 Mn |
| Dec 29, 2024 | 109.30 Mn |
| Dec 29, 2024 | 109.30 Mn |
| Sep 29, 2024 | 113.10 Mn |
| Sep 29, 2024 | 113.10 Mn |
| Jun 30, 2024 | 116.10 Mn |
| Jun 30, 2024 | 116.10 Mn |
| Mar 31, 2024 | 114.90 Mn |
| Mar 31, 2024 | 114.90 Mn |
| Dec 31, 2023 | 115.40 Mn |
| Dec 31, 2023 | 115.40 Mn |